Gesina van Lijnschoten

The BRAF V600E mutation is an independent prognostic factor for survival in stage II and stage III colon cancer patients

Arantza Fariña Sarasqueta, Gesina van Lijnschoten, Elna Moerland et al. · Annals of Oncology · 2010 · 263 citations · Full text

Oncology, Stage Ii, Medicine +8

Disruption of a Ciliary B9 Protein Complex Causes Meckel Syndrome

William E. Dowdle, Jon F. Robinson, Andreas Kneist et al. · The American Journal of Human Genetics · 2011 · 151 citations · Full text

Medicine, Pathogenesis, Immunology +1

Pressurized Intraperitoneal Aerosol Chemotherapy (Oxaliplatin) for Unresectable Colorectal Peritoneal Metastases: A Multicenter, Single-Arm, Phase II Trial (CRC-PIPAC)

Koen P. Rovers, Emma C. E. Wassenaar, Robin J. Lurvink et al. · Annals of Surgical Oncology · 2021 · 55 citations

Intraperitoneal Aerosol Chemotherapy, Surgical Oncology, Phase Ii Trial +6

<scp>COVID</scp>‐19 during pregnancy: non‐reassuring fetal heart rate, placental pathology and coagulopathy

J. E. Mongula, Maria Wilhelmina Elisabeth Frenken, Gesina van Lijnschoten et al. · Ultrasound in Obstetrics and Gynecology · 2020 · 54 citations · Full text

SNaPshot and StripAssay as Valuable Alternatives to Direct Sequencing for KRAS Mutation Detection in Colon Cancer Routine Diagnostics

Arantza Fariña Sarasqueta, Elna Moerland, Hanneke de Bruyne et al. · Journal of Molecular Diagnostics · 2011 · 47 citations · Full text

Valuable Alternatives, Oncology, Functional Genomics +13